Current progress with primate embryonic stem cells.

James A. Byrne, Shoukhrat Mitalipov, Don P. Wolf

    Research output: Contribution to journalArticle

    10 Citations (Scopus)

    Abstract

    Embryonic stem cells (ESCs) can proliferate indefinitely, maintain an undifferentiated pluripotent state and differentiate into any cell type. Differentiation of ESCs into various specific cell-types may be able to cure or alleviate the symptoms of various degenerative diseases. Unresolved issues regarding maintaining function, possible apoptosis and tumor formation in vivo mean a prudent approach should be taken towards advancing ESCs into human clinical trials. Rhesus macaques provide the ideal model organism for testing the feasibility, efficacy and safety of ESC based therapies and significant numbers of primate ESC lines are now available. In this review, we will summarize progress in evaluating the genetic and epigenetic integrity of primate ESCs, examine their current use in pre-clinical trials and discuss the potential of producing ESC-derived cell populations that are genetically identical (isogenic) to the host by somatic cell nuclear transfer.

    Original languageEnglish (US)
    Pages (from-to)127-138
    Number of pages12
    JournalCurrent stem cell research & therapy
    Volume1
    Issue number2
    DOIs
    StatePublished - May 2006

    Fingerprint

    Embryonic Stem Cells
    Primates
    Clinical Trials
    Cell- and Tissue-Based Therapy
    Macaca mulatta
    Epigenomics
    Apoptosis
    Safety
    Cell Line
    Population
    Neoplasms

    ASJC Scopus subject areas

    • Medicine (miscellaneous)

    Cite this

    Current progress with primate embryonic stem cells. / Byrne, James A.; Mitalipov, Shoukhrat; Wolf, Don P.

    In: Current stem cell research & therapy, Vol. 1, No. 2, 05.2006, p. 127-138.

    Research output: Contribution to journalArticle

    Byrne, James A. ; Mitalipov, Shoukhrat ; Wolf, Don P. / Current progress with primate embryonic stem cells. In: Current stem cell research & therapy. 2006 ; Vol. 1, No. 2. pp. 127-138.
    @article{701219ba4af342ec9d55e95dbdbec3e3,
    title = "Current progress with primate embryonic stem cells.",
    abstract = "Embryonic stem cells (ESCs) can proliferate indefinitely, maintain an undifferentiated pluripotent state and differentiate into any cell type. Differentiation of ESCs into various specific cell-types may be able to cure or alleviate the symptoms of various degenerative diseases. Unresolved issues regarding maintaining function, possible apoptosis and tumor formation in vivo mean a prudent approach should be taken towards advancing ESCs into human clinical trials. Rhesus macaques provide the ideal model organism for testing the feasibility, efficacy and safety of ESC based therapies and significant numbers of primate ESC lines are now available. In this review, we will summarize progress in evaluating the genetic and epigenetic integrity of primate ESCs, examine their current use in pre-clinical trials and discuss the potential of producing ESC-derived cell populations that are genetically identical (isogenic) to the host by somatic cell nuclear transfer.",
    author = "Byrne, {James A.} and Shoukhrat Mitalipov and Wolf, {Don P.}",
    year = "2006",
    month = "5",
    doi = "10.2174/157488806776956913",
    language = "English (US)",
    volume = "1",
    pages = "127--138",
    journal = "Current Stem Cell Research and Therapy",
    issn = "1574-888X",
    publisher = "Bentham Science Publishers B.V.",
    number = "2",

    }

    TY - JOUR

    T1 - Current progress with primate embryonic stem cells.

    AU - Byrne, James A.

    AU - Mitalipov, Shoukhrat

    AU - Wolf, Don P.

    PY - 2006/5

    Y1 - 2006/5

    N2 - Embryonic stem cells (ESCs) can proliferate indefinitely, maintain an undifferentiated pluripotent state and differentiate into any cell type. Differentiation of ESCs into various specific cell-types may be able to cure or alleviate the symptoms of various degenerative diseases. Unresolved issues regarding maintaining function, possible apoptosis and tumor formation in vivo mean a prudent approach should be taken towards advancing ESCs into human clinical trials. Rhesus macaques provide the ideal model organism for testing the feasibility, efficacy and safety of ESC based therapies and significant numbers of primate ESC lines are now available. In this review, we will summarize progress in evaluating the genetic and epigenetic integrity of primate ESCs, examine their current use in pre-clinical trials and discuss the potential of producing ESC-derived cell populations that are genetically identical (isogenic) to the host by somatic cell nuclear transfer.

    AB - Embryonic stem cells (ESCs) can proliferate indefinitely, maintain an undifferentiated pluripotent state and differentiate into any cell type. Differentiation of ESCs into various specific cell-types may be able to cure or alleviate the symptoms of various degenerative diseases. Unresolved issues regarding maintaining function, possible apoptosis and tumor formation in vivo mean a prudent approach should be taken towards advancing ESCs into human clinical trials. Rhesus macaques provide the ideal model organism for testing the feasibility, efficacy and safety of ESC based therapies and significant numbers of primate ESC lines are now available. In this review, we will summarize progress in evaluating the genetic and epigenetic integrity of primate ESCs, examine their current use in pre-clinical trials and discuss the potential of producing ESC-derived cell populations that are genetically identical (isogenic) to the host by somatic cell nuclear transfer.

    UR - http://www.scopus.com/inward/record.url?scp=36448970284&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=36448970284&partnerID=8YFLogxK

    U2 - 10.2174/157488806776956913

    DO - 10.2174/157488806776956913

    M3 - Article

    VL - 1

    SP - 127

    EP - 138

    JO - Current Stem Cell Research and Therapy

    JF - Current Stem Cell Research and Therapy

    SN - 1574-888X

    IS - 2

    ER -